32.18
price down icon5.38%   -1.83
after-market Handel nachbörslich: 31.95 -0.23 -0.71%
loading

Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
17.74%
1.998
2.429 2.582 2.822 2.208
Cost Of Revenue
246.98%
3.272
0.943 1.183 1.555 -
Gross Profit
185.73%
-1.274
1.486 1.399 1.267 -
Operating Expenses
54.06%
27.02
17.54 23.88 16.82 79.52
Benefits Costs and Expenses
63.90%
30.29
18.48 25.06 18.38 81.73
Costs And Expenses
63.90%
30.29
18.48 25.06 18.38 79.52
Depreciation and Amortization
0.00%
0.50
0.50 0.50 0.50 0.90
Operating Income/Loss
76.26%
-28.30
-16.05 -22.48 -15.55 -77.32
Income/Loss From Continuing Operations Before Tax
68.14%
-28.30
-16.83 -22.48 -15.55 -78.78
Income/Loss From Continuing Operations After Tax
68.00%
-28.27
-16.83 -22.11 -14.21 -78.78
Net Income/Loss
68.00%
-28.27
-16.83 -22.11 -14.21 -78.78
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23.62%
7.3273
5.9272 -22.40 62.12 4.0851
Diluted Average Shares
23.62%
7.3273
5.9272 -22.40 62.12 4.0851
Basic Earnings Per Share
35.92%
-3.86
-2.84 -171.94 -0.23 -19.28
Diluted Earnings Per Share
35.92%
-3.86
-2.84 -171.94 -0.23 -19.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):